Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000799851 | SCV000939533 | pathogenic | Fanconi anemia | 2023-01-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr86*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with FANCA-related conditions (PMID: 21520333). ClinVar contains an entry for this variant (Variation ID: 645709). For these reasons, this variant has been classified as Pathogenic. |
Myriad Genetics, |
RCV001256218 | SCV001442399 | likely pathogenic | Fanconi anemia complementation group A | 2019-04-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001256218 | SCV004196063 | pathogenic | Fanconi anemia complementation group A | 2023-08-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001256218 | SCV005639572 | likely pathogenic | Fanconi anemia complementation group A | 2024-06-14 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV001256218 | SCV001425621 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. |